Kelle M Franklin1, Sheketha R Hauser1, Amy W Lasek2, Richard L Bell1, William J McBride1,3. 1. Department of Psychiatry, Institute of Psychiatric Research, Indiana University School of Medicine, Indianapolis, Indiana. 2. Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois. 3. Department of Biochemistry, Indiana University School of Medicine, Indianapolis, Indiana.
Abstract
BACKGROUND: The P2X4 receptor (P2X4R) is thought to be involved in regulating alcohol-consuming behaviors, and ethanol (EtOH) has been reported to inhibit P2X4Rs. Ivermectin is an antiparasitic agent that acts as a positive allosteric modulator of the P2X4R. This study examined the effects of systemically and centrally administered ivermectin on alcohol drinking of replicate lines of high-alcohol-drinking (HAD-1/HAD-2) rats, and the effects of lentiviral-delivered short-hairpin RNAs (shRNAs) targeting P2rx4 on EtOH intake of female HAD-2 rats. METHODS: For the first experiment, adult male HAD-1 and HAD-2 rats were given 24-hour free-choice access to 15% EtOH versus water. Dose-response effects of ivermectin (1.5 to 7.5 mg/kg, intraperitoneally [i.p.]) on EtOH intake were determined; the effects of ivermectin were then examined for 2% w/v sucrose intake over 5 consecutive days. In the second experiment, female HAD-2 rats were trained to consume 15% EtOH under 2-hour limited access conditions, and dose-response effects of intracerebroventricular (ICV) administration of ivermectin (0.5 to 2.0 μg) were determined over 5 consecutive days. The third experiment determined the effects of microinfusion of a lentivirus expressing P2rx4 shRNAs into the posterior ventral tegmental area (VTA) on 24-hour EtOH free-choice drinking of female HAD-2 rats. RESULTS: The highest i.p. dose of ivermectin reduced alcohol drinking (30 to 45%) in both rat lines, but did not alter sucrose intake. HAD-2 rats appeared to be more sensitive than HAD-1 rats to the effects of ivermectin. ICV administration of ivermectin reduced 2-hour limited access intake (~35%) of female HAD-2 rats; knockdown of P2rx4 expression in the posterior VTA reduced 24-hour free-choice EtOH intake (~20%). CONCLUSIONS: Overall, the results of this study support a role for P2X4Rs within the mesolimbic system in mediating alcohol-drinking behavior.
BACKGROUND: The P2X4 receptor (P2X4R) is thought to be involved in regulating alcohol-consuming behaviors, and ethanol (EtOH) has been reported to inhibit P2X4Rs. Ivermectin is an antiparasitic agent that acts as a positive allosteric modulator of the P2X4R. This study examined the effects of systemically and centrally administered ivermectin on alcohol drinking of replicate lines of high-alcohol-drinking (HAD-1/HAD-2) rats, and the effects of lentiviral-delivered short-hairpin RNAs (shRNAs) targeting P2rx4 on EtOH intake of female HAD-2 rats. METHODS: For the first experiment, adult male HAD-1 and HAD-2 rats were given 24-hour free-choice access to 15% EtOH versus water. Dose-response effects of ivermectin (1.5 to 7.5 mg/kg, intraperitoneally [i.p.]) on EtOH intake were determined; the effects of ivermectin were then examined for 2% w/v sucrose intake over 5 consecutive days. In the second experiment, female HAD-2 rats were trained to consume 15% EtOH under 2-hour limited access conditions, and dose-response effects of intracerebroventricular (ICV) administration of ivermectin (0.5 to 2.0 μg) were determined over 5 consecutive days. The third experiment determined the effects of microinfusion of a lentivirus expressing P2rx4 shRNAs into the posterior ventral tegmental area (VTA) on 24-hour EtOH free-choice drinking of female HAD-2 rats. RESULTS: The highest i.p. dose of ivermectin reduced alcohol drinking (30 to 45%) in both rat lines, but did not alter sucrose intake. HAD-2 rats appeared to be more sensitive than HAD-1 rats to the effects of ivermectin. ICV administration of ivermectin reduced 2-hour limited access intake (~35%) of female HAD-2 rats; knockdown of P2rx4 expression in the posterior VTA reduced 24-hour free-choice EtOH intake (~20%). CONCLUSIONS: Overall, the results of this study support a role for P2X4Rs within the mesolimbic system in mediating alcohol-drinking behavior.
Authors: James M Murphy; Robert B Stewart; Richard L Bell; Nancy E Badia-Elder; Lucinda G Carr; William J McBride; Lawrence Lumeng; Ting-Kai Li Journal: Behav Genet Date: 2002-09 Impact factor: 2.805
Authors: Olga Ostrovskaya; Liana Asatryan; Letisha Wyatt; Maya Popova; Kaixun Li; Robert W Peoples; Ronald L Alkana; Daryl L Davies Journal: J Pharmacol Exp Ther Date: 2011-01-06 Impact factor: 4.030
Authors: Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng Journal: Pharmacol Biochem Behav Date: 2012-07-25 Impact factor: 3.533
Authors: Boris Tabakoff; Laura Saba; Morton Printz; Pam Flodman; Colin Hodgkinson; David Goldman; George Koob; Heather N Richardson; Katerina Kechris; Richard L Bell; Norbert Hübner; Matthias Heinig; Michal Pravenec; Jonathan Mangion; Lucie Legault; Maurice Dongier; Katherine M Conigrave; John B Whitfield; John Saunders; Bridget Grant; Paula L Hoffman Journal: BMC Biol Date: 2009-10-27 Impact factor: 7.431
Authors: David B Sattelle; Steven D Buckingham; Miki Akamatsu; Kazuhiko Matsuda; Ilse S Pienaar; Ilse Pienaar; Andrew K Jones; Benedict M Sattelle; Andrew Almond; Charles D Blundell Journal: Biochem Pharmacol Date: 2009-06-21 Impact factor: 5.858
Authors: William J McBride; Mark W Kimpel; Jeanette N McClintick; Zheng-Ming Ding; Petri Hyytia; Giancarlo Colombo; Howard J Edenberg; Lawrence Lumeng; Richard L Bell Journal: Pharmacol Biochem Behav Date: 2012-05-10 Impact factor: 3.533
Authors: Kelle M Franklin; Liana Asatryan; Michael W Jakowec; James R Trudell; Richard L Bell; Daryl L Davies Journal: Front Neurosci Date: 2014-06-24 Impact factor: 4.677
Authors: R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman Journal: Int Rev Neurobiol Date: 2016-03-21 Impact factor: 3.230
Authors: Sheraz Khoja; Nhat Huynh; Alicia M P Warnecke; Liana Asatryan; Michael W Jakowec; Daryl L Davies Journal: Psychopharmacology (Berl) Date: 2018-03-02 Impact factor: 4.530
Authors: Zheng-Ming Ding; Cynthia M Ingraham; Sheketha R Hauser; Amy W Lasek; Richard L Bell; William J McBride Journal: Alcohol Clin Exp Res Date: 2017-10-03 Impact factor: 3.455
Authors: Kshitija Dhuna; Matthew Felgate; Stefan M Bidula; Samuel Walpole; Lucka Bibic; Brett A Cromer; Jesus Angulo; Julie Sanderson; Martin J Stebbing; Leanne Stokes Journal: Mol Pharmacol Date: 2018-12-13 Impact factor: 4.436